HomeAI · summaries
Storia in 3 fonti
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
On Thursday, the public had the first chance to air their grievances about the FDA’s controversial Commissioner’s National Priority Voucher (CNPV) pilot program, the flagship initiative of recently | On Thursday, the public had the first chance to air their grievances about the FDA’s controversial Commissioner’s National Priority Voucher (CNPV) pilot program, the flagship initiative of recently departed agency leader Marty Makary, M.D.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Drug companies, patient groups urge FDA to pause commissioner’s voucher program
The White House has used the program to reward companies that help its political goals.
- ·
fiercebiotech.com
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
On Thursday, the public had the first chance to air their grievances about the FDA’s controversial Commissioner’s National Priority Voucher (CNPV) pilot program, the flagship…
- ·
endpoints.news
Industry seeks more clarity on commissioner's voucher program
Pharma and rare disease advocates press FDA at public hearing on Makary's National Priority Voucher pilot, urging formal rulemaking; 21 vouchers awarded so far.